Stay updated on Sotatercept in PAH: New Intermediate-High Risk Clinical Trial
Sign up to get notified when there's something new on the Sotatercept in PAH: New Intermediate-High Risk Clinical Trial page.

Latest updates to the Sotatercept in PAH: New Intermediate-High Risk Clinical Trial page
- CheckyesterdayChange DetectedNo additions or deletions were recorded for the page. The Study Details content remains as published.SummaryDifference0.0%

- Check8 days agoChange DetectedNo textual changes were provided for this page; therefore, there are no updates to describe.SummaryDifference0.0%

- Check15 days agoChange DetectedThe page revision label changed from v3.6.2 to v3.6.3, signaling a minor update to the page's template or accompanying documentation without altering visible content.SummaryDifference0.0%

- Check22 days agoChange DetectedNew revision v3.6.2 has been added to the study documents section, and revision v3.6.0 has been removed. This reflects an update to the formal protocol and statistical analysis plan referenced on the page.SummaryDifference0.0%

- Check29 days agoChange DetectedNo additions or deletions were provided, so no changes to the page were detected. The page content remains as recorded.SummaryDifference0.0%

- Check36 days agoChange DetectedEnrollment status updated to indicate no further recruitment. New navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and expanded content for REVEAL Lite 2 risk-score endpoints have been added to the page.SummaryDifference0.6%

Stay in the know with updates to Sotatercept in PAH: New Intermediate-High Risk Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sotatercept in PAH: New Intermediate-High Risk Clinical Trial page.